NR4A1 and breast cancer: This review examines current approaches to axillary management in HER2-negative, hormone receptor-positive early breast cancer, with a focus on surgical de-escalation, systemic therapy integration, radiotherapy alternatives, and emerging tools for personalized decision-making.